Simon Waddington

 

Simon serves as the President and CEO of Abunda Corporation, an early-stage, venture-backed start-up working at the forefront of nutritional science and human health. Simon also serves as Entrepreneur-in-Residence at Burrill & Company, a global venture capital firm dedicated to the life sciences, where he supports the formation and management of start-up companies.
Prior to his current role he spent more than a decade as a venture capitalist. He was a Managing Partner at PolyTechnos Venture-Partners based in Munich, Germany where he led and supported investments in numerous life science and materials-related companies across Europe, Israel, and the United States. Prior to that, he started and ran Monsanto's European corporate venturing activities from Brussels, Belgium, covering opportunities across the medical, agricultural, nutrition, healthcare services and materials arenas. Before that he was Product Development Manager for Zeneca's biopolymers business in the U.K., which pioneered the fermentation-based production of biodegradable polymers from renewable feedstocks. Prior to that he served as a Senior Research Scientist for ICI specializing in surface and interface science. Simon holds a Ph.D. in physics from Liverpool University (UK) and an MBA from Harvard Business School.

Organization: Abunda Corporation

Related Challenge: Health